Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274Y

作者: A. J. Burnham , T. Baranovich , B. M. Marathe , J. Armstrong , R. G. Webster

DOI: 10.1128/AAC.02628-13

关键词:

摘要: Influenza B viruses cause annual outbreaks of respiratory illness in humans and are increasingly recognized as a major influenza-associated pediatric mortality. Neuraminidase (NA) inhibitors (NAIs) the only available therapy for patients infected with influenza viruses, potential emergence NAI-resistant is public health concern. The NA substitutions located within enzyme active site could not reduce NAI susceptibility virus but also affect fitness. In this study, we investigated effect single on fitness B/Yamanashi/166/1998 (Yamagata lineage). We generated recombinant containing either wild-type (WT) or substitution catalytic (R371K) framework (E119A, D198E, D198Y, I222T, H274Y, N294S) residues. assessed susceptibility, biochemical properties, protein expression, replication vitro differentiated normal human bronchial epithelial (NHBE) cells. Our results showed that four (D198E, conferred reduced inhibition by oseltamivir three R371K) highly oseltamivir, zanamivir, peramivir. All substitutions, except D198Y R371K, were genetically stable after seven passages MDCK Cell surface expression was significantly increased H274Y N294S substitutions. Viruses E119A, attenuated efficiency NHBE Overall, E119A possess comparable to NAI-susceptible virus, acquisition these should be closely monitored.

参考文章(73)
Michael G. Ison, Alan Hay, Antivirals: Targets and use John Wiley & Sons, Ltd. pp. 392- 418 ,(2013) , 10.1002/9781118636817.CH25
Michael W. Wathen, Mario Barro, Rick A. Bright, Antivirals in seasonal and pandemic influenza—future perspectives * Influenza and Other Respiratory Viruses. ,vol. 7, pp. 76- 80 ,(2013) , 10.1111/IRV.12049
Arnold S. Monto, Robert A. Lamb., Robert G. Webster, Thomas J. Braciale, Textbook of Influenza ,(2013)
S. Hatakeyama, M. Ozawa, Y. Kawaoka, In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors Clinical Microbiology and Infection. ,vol. 17, pp. 1332- 1335 ,(2011) , 10.1111/J.1469-0691.2010.03313.X
L V Gubareva, R Bethell, G J Hart, K G Murti, C R Penn, R G Webster, Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. Journal of Virology. ,vol. 70, pp. 1818- 1827 ,(1996) , 10.1128/JVI.70.3.1818-1827.1996
J.A.L. Ives, J.A. Carr, D.B. Mendel, C.Y. Tai, R. Lambkin, L. Kelly, J.S. Oxford, F.G. Hayden, N.A. Roberts, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Research. ,vol. 55, pp. 307- 317 ,(2002) , 10.1016/S0166-3542(02)00053-0
Robert B. Belshe, Kathleen Coelingh, Christopher S. Ambrose, Jennifer C. Woo, Xionghua Wu, Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. ,vol. 28, pp. 2149- 2156 ,(2010) , 10.1016/J.VACCINE.2009.11.068
Yun Hee Kim, Hyun Soo Kim, Sung Hwan Cho, Sang Heui Seo, Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunology. ,vol. 22, pp. 423- 430 ,(2009) , 10.1089/VIM.2009.0045
Tiffany G. Sheu, Varough M. Deyde, Rebecca J. Garten, Alexander I. Klimov, Larisa V. Gubareva, Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing Antiviral Research. ,vol. 85, pp. 354- 360 ,(2010) , 10.1016/J.ANTIVIRAL.2009.10.022
Andrew J. Burnham, Tatiana Baranovich, Elena A. Govorkova, Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance. Antiviral Research. ,vol. 100, pp. 520- 534 ,(2013) , 10.1016/J.ANTIVIRAL.2013.08.023